Alina Pervez , Areesha Ahmer , Omar Mahmud , Russell Seth Martins , Hawra Hussain , Sameen Nasir , Sonia Pirzada , Mohsin Ali Mustafa , Uswah Siddiqi , Maheen Zakaria , Nashia Ali Rizvi , Ainan Arshad , Adil H. Haider , Sarah Nadeem
{"title":"南亚 2 型糖尿病管理临床实践指南：系统回顾。","authors":"Alina Pervez , Areesha Ahmer , Omar Mahmud , Russell Seth Martins , Hawra Hussain , Sameen Nasir , Sonia Pirzada , Mohsin Ali Mustafa , Uswah Siddiqi , Maheen Zakaria , Nashia Ali Rizvi , Ainan Arshad , Adil H. Haider , Sarah Nadeem","doi":"10.1016/j.dsx.2024.103094","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Clinical practice guidelines (CPGs) are a helpful tool for the evidence-based management of Type 2 Diabetes Mellitus (T2D). The aim of this systematic review was to synthesize and appraise the scope and quality of South Asian T2D CPGs.</p></div><div><h3>Methods</h3><p>This PROPSERO registered (CRD42023425150) systematic review adhered to the 2020 PRISMA guidelines. We searched the PubMed, Embase, Cochrane, and Google Scholar databases for relevant guidelines. Data synthesis was performed using a qualitative approach and methodological quality was assessed using the Appraisal of Guidelines for Research and Evaluation (AGREE) II tool.</p></div><div><h3>Results</h3><p>We identified eleven unique CPGs (three each from Pakistan and Sri Lanka, two from India, and one each from Bangladesh, Nepal, and Bhutan) which were published or updated between 2017 and 2023. The CPGs included recommendations regarding screening, diagnosis, prevention, and management of T2D and its acute and chronic complications, comorbidities, and fasting with T2D. The AGREE II mean domain scores ranged from 37 % to 80 %; three CPGs were ‘recommended for clinical use,’ seven were ‘recommended for use with modifications’ and one was deemed unfit for implementation.</p></div><div><h3>Conclusion</h3><p>The present review summarized and appraised broadly CPGs from South Asia for T2D and can help direct improvements to future iterations.</p></div>","PeriodicalId":48252,"journal":{"name":"Diabetes & Metabolic Syndrome-Clinical Research & Reviews","volume":"18 7","pages":"Article 103094"},"PeriodicalIF":4.3000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Clinical Practice Guidelines for the Management of Type 2 Diabetes in South Asia: A Systematic Review\",\"authors\":\"Alina Pervez , Areesha Ahmer , Omar Mahmud , Russell Seth Martins , Hawra Hussain , Sameen Nasir , Sonia Pirzada , Mohsin Ali Mustafa , Uswah Siddiqi , Maheen Zakaria , Nashia Ali Rizvi , Ainan Arshad , Adil H. Haider , Sarah Nadeem\",\"doi\":\"10.1016/j.dsx.2024.103094\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>Clinical practice guidelines (CPGs) are a helpful tool for the evidence-based management of Type 2 Diabetes Mellitus (T2D). The aim of this systematic review was to synthesize and appraise the scope and quality of South Asian T2D CPGs.</p></div><div><h3>Methods</h3><p>This PROPSERO registered (CRD42023425150) systematic review adhered to the 2020 PRISMA guidelines. We searched the PubMed, Embase, Cochrane, and Google Scholar databases for relevant guidelines. Data synthesis was performed using a qualitative approach and methodological quality was assessed using the Appraisal of Guidelines for Research and Evaluation (AGREE) II tool.</p></div><div><h3>Results</h3><p>We identified eleven unique CPGs (three each from Pakistan and Sri Lanka, two from India, and one each from Bangladesh, Nepal, and Bhutan) which were published or updated between 2017 and 2023. The CPGs included recommendations regarding screening, diagnosis, prevention, and management of T2D and its acute and chronic complications, comorbidities, and fasting with T2D. The AGREE II mean domain scores ranged from 37 % to 80 %; three CPGs were ‘recommended for clinical use,’ seven were ‘recommended for use with modifications’ and one was deemed unfit for implementation.</p></div><div><h3>Conclusion</h3><p>The present review summarized and appraised broadly CPGs from South Asia for T2D and can help direct improvements to future iterations.</p></div>\",\"PeriodicalId\":48252,\"journal\":{\"name\":\"Diabetes & Metabolic Syndrome-Clinical Research & Reviews\",\"volume\":\"18 7\",\"pages\":\"Article 103094\"},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2024-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diabetes & Metabolic Syndrome-Clinical Research & Reviews\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1871402124001553\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes & Metabolic Syndrome-Clinical Research & Reviews","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1871402124001553","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
Clinical Practice Guidelines for the Management of Type 2 Diabetes in South Asia: A Systematic Review
Background
Clinical practice guidelines (CPGs) are a helpful tool for the evidence-based management of Type 2 Diabetes Mellitus (T2D). The aim of this systematic review was to synthesize and appraise the scope and quality of South Asian T2D CPGs.
Methods
This PROPSERO registered (CRD42023425150) systematic review adhered to the 2020 PRISMA guidelines. We searched the PubMed, Embase, Cochrane, and Google Scholar databases for relevant guidelines. Data synthesis was performed using a qualitative approach and methodological quality was assessed using the Appraisal of Guidelines for Research and Evaluation (AGREE) II tool.
Results
We identified eleven unique CPGs (three each from Pakistan and Sri Lanka, two from India, and one each from Bangladesh, Nepal, and Bhutan) which were published or updated between 2017 and 2023. The CPGs included recommendations regarding screening, diagnosis, prevention, and management of T2D and its acute and chronic complications, comorbidities, and fasting with T2D. The AGREE II mean domain scores ranged from 37 % to 80 %; three CPGs were ‘recommended for clinical use,’ seven were ‘recommended for use with modifications’ and one was deemed unfit for implementation.
Conclusion
The present review summarized and appraised broadly CPGs from South Asia for T2D and can help direct improvements to future iterations.
期刊介绍：
Diabetes and Metabolic Syndrome: Clinical Research and Reviews is the official journal of DiabetesIndia. It aims to provide a global platform for healthcare professionals, diabetes educators, and other stakeholders to submit their research on diabetes care.
Types of Publications:
Diabetes and Metabolic Syndrome: Clinical Research and Reviews publishes peer-reviewed original articles, reviews, short communications, case reports, letters to the Editor, and expert comments. Reviews and mini-reviews are particularly welcomed for areas within endocrinology undergoing rapid changes.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
